Elotuzumab Enhances CD16‐Independent NK Cell‐Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell‐Enhancing GenesYan-Hua Wang, Junji Tanaka|Journal of Immunology Research|2024Cited by 8